Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing

Suraj Kumar Singh1, Shradha Devi Dwivedi1, Krishna Yadav2

  • 1University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492010, Chhattisgarh, India.

Biomedicines
|February 25, 2023
PubMed

Insights

This study explores molecular mechanisms regulating wound healing, focusing on diabetic complications. It identifies key therapeutic targets like growth factors and immunomodulators for improved treatment strategies.

Area of Science:

  • Biomedical Sciences
  • Molecular Biology
  • Immunology

Background:

  • Chronic inflammation significantly impacts wound healing globally.
  • Achieving balance in the inflammatory cascade is crucial for effective wound-healing drug development.
  • Diabetic wound healing presents unique molecular and cellular challenges.

Purpose of the Study:

  • To elucidate molecular and cellular mechanisms governing wound healing.
  • To review recent advancements in understanding diabetic wound healing.
  • To identify potential therapeutic targets for enhancing wound repair.

Main Methods:

  • Review of current scientific literature on wound healing mechanisms.
  • Analysis of molecular and cellular events specific to diabetic wound healing.
  • Investigation of factors and agents that facilitate wound repair.

Main Results:

  • Identified key molecular targets including neuropeptides (e.g., substance P), T cell immune response cDNA 7, and microRNA (miRNA).
  • Highlighted the role of growth factors like fibroblast growth factor and thymosin beta 4.
  • Recognized immunomodulators as significant therapeutic targets.

Conclusions:

  • Advances in research reveal promising molecular targets for wound healing therapy and diagnosis.
  • Understanding cellular physiology and pathology is key to developing effective treatments.
  • Targeting specific molecular pathways offers potential for improved wound healing outcomes, particularly in diabetic patients.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
323